RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Feinstein to Cell Line

This is a "connection" page, showing publications Paul Feinstein has written about Cell Line.
Connection Strength

0.325
  1. Jamet S, Bubnell J, Pfister P, Tomoiaga D, Rogers ME, Feinstein P. In Vitro Mutational Analysis of the ?2 Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor. PLoS One. 2015; 10(10):e0141696.
    View in: PubMed
    Score: 0.105
  2. Bubnell J, Jamet S, Tomoiaga D, D'Hulst C, Krampis K, Feinstein P. In Vitro Mutational and Bioinformatics Analysis of the M71 Odorant Receptor and Its Superfamily. PLoS One. 2015; 10(10):e0141712.
    View in: PubMed
    Score: 0.105
  3. Bubnell J, Pfister P, Sapar ML, Rogers ME, Feinstein P. ?2 adrenergic receptor fluorescent protein fusions traffic to the plasma membrane and retain functionality. PLoS One. 2013; 8(9):e74941.
    View in: PubMed
    Score: 0.091
  4. Feinstein PG, Schrader KA, Bakalyar HA, Tang WJ, Krupinski J, Gilman AG, Reed RR. Molecular cloning and characterization of a Ca2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci U S A. 1991 Nov 15; 88(22):10173-7.
    View in: PubMed
    Score: 0.020
  5. Krupinski J, Coussen F, Bakalyar HA, Tang WJ, Feinstein PG, Orth K, Slaughter C, Reed RR, Gilman AG. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science. 1989 Jun 30; 244(4912):1558-64.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support